MS Briefs

Body Composition, Disability in People with Multiple Sclerosis

Mult Scler Relat Disord; ePub 2019 Jan 3; Pilutti, et al


 

Persons with multiple sclerosis (MS) who have greater disability exhibit higher body fat and lower bone tissue content and density than those with mild disability, a recent study found. Researchers conducted a cross-sectional investigation of 47 ambulatory persons with relapsing remitting MS who were grouped by Expanded Disability Status Scale (EDSS) scores as having mild (1.0‒4.0; n=26) or moderate (4.5‒6.5; n=21) disability. Main outcome measures were whole-body and regional soft tissue composition (%body fat [BF], fat mass [FM], and fat-free soft tissue mass [FFM]), bone mineral content (BMC), and bone mineral density (BMD). Other outcomes included physical fitness, mobility, cognitive processing speed, symptoms, and health-related quality of life (HRQOL). They found:

  • Whole-body and regional %BF and FM were significantly higher, and whole-body and appendicular BMC and BMD were significantly lower in participants with moderate disability than those with mild disability.
  • There were no significant differences in whole-body or regional FFM by disability status.
  • In the overall sample, body fat correlated significantly with cardiorespiratory fitness, pain symptoms, and psychological HRQOL.
  • FFM and BMC correlated primarily with measures of muscular strength.

Pilutti LA, Motl RW. Body composition and disability in people with multiple sclerosis: A dual-energy x-ray absorptiometry study. [Published online ahead of print January 3, 2019]. Mult Scler Relat Disord . doi:10.1016/j.msard.2019.01.009.

Recommended Reading

Virus-Specific T-Cell Infusions May Resolve Progressive Multifocal Leukoencephalopathy
ICYMI Multiple Sclerosis
Real-world data reveal long-lasting effects achieved with RRMS treatments
ICYMI Multiple Sclerosis
Food allergies linked to increased MS relapses, lesions
ICYMI Multiple Sclerosis
Integrated analysis suggests cladribine’s safety in MS
ICYMI Multiple Sclerosis
Does rituximab delay disability progression in patients with secondary progressive MS?
ICYMI Multiple Sclerosis
Daclizumab beta may be superior to interferon beta on MS disability progression
ICYMI Multiple Sclerosis
Interferon Beta May Not Affect Pregnancy Outcomes in MS
ICYMI Multiple Sclerosis
Autologous Hematopoietic Stem Cells May Treat Aggressive MS Effectively
ICYMI Multiple Sclerosis
DMTs, stem cell transplants both reduce disease progression in MS
ICYMI Multiple Sclerosis
Examining Pseudobulbar Affect in Multiple Sclerosis
ICYMI Multiple Sclerosis